Monographs: Dosage forms: Specific monographs: Pentamidine isetionate for injection (Pentamidini isetionatis ad injectionem)2015-01
Description. A white or almost white, crystalline powder. Category. Antipneumocystosis, antitoxoplasmosis and antitrypanosomal activity. Labelling. The designation on the container should state that Pentamidine isetionate injection should be used immediately after preparation for intravenous administration. Additional information. Strength in the current WHO Model list of essential medicines (EML): 200 mg (as isetionate) in vial. Additional available strength: 300 mg (as isetionate) in vial. Pentamidine isetionate is hygroscopic. The injection deteriorates on storage. Requirements The powder for injections and the reconstituted solution for injections comply with the monograph for Parenteral preparations. Definition. Pentamidine isetionate powder for injections is a sterile powder of pentamidine isetionate. The powder is sterilized by a suitable method (see 5.8 Methods of sterilization). The container of Pentamidine isetionate powder for injections contains not less than 90.0% and not more than 110.0% of the amount of C19H24N4O2,2C2H6O4S stated on the label. Identity tests
Clarity of solution. A solution of the powder for injections equivalent to 0.5 g of Pentamidine isetionate in 10 mL of carbon-dioxide-free water R is clear. (Keep this solution for the "pH value".) pH value (1.13). pH of the solution prepared above for the test of clarity and colour, 4.5–6.5. Related substances Carry out the test as described under 1.14.1 Chromatography, Thin-layer chromatography using silica gel R6, activated at 105 °C for 1 hour, as the coating substance, and as the mobile phase the upper layer obtained by shaking together 10 volumes of water, 8 volumes of 1-butanol R and 2 volumes of glacial acetic acid R. Apply separately to the plate 10 μL of each of the following two solutions. For solution (A) dissolve a quantity of the powder for injections equivalent to 0.1 g of Pentamidine isetionate in 2 mL of methanol R. For solution (B) dilute 1 mL of solution A to 200 mL with methanol R. After removing the plate from the chromatographic chamber allow it to dry in air and examine the chromatogram in ultraviolet light (254 nm). Any spot obtained with solution A, other than the principal spot, is not more intense than that obtained with solution B. Assay Mix the contents of 10 containers and carry out the assay as described. Use Method A as described under 2.10 Determination of nitrogen with a quantity of the powder for injections equivalent to about 0.4 g of Pentamidine isetionate, accurately weighed, and 9 mL of nitrogen-free sulfuric acid (~1760 g/L) TS. Each mL of sulfuric acid (0.05 mol/L) VS is equivalent to 14.82 mg of C19H24N4O2,2C2H6O4S. Bacterial endotoxins. Carry out the test as described under 3.4 Test for bacterial endotoxins; contains less than 1.25 IU of endotoxin per mg Pentamidine isetionate. |